(Q69259448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

title

A pharmacological evaluation of a new 3-month depot preparation of buserelin for prostatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

author name string

J Waxman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

J Sandow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

H Thomas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

N James

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

G Williams

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

30 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

219-220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00689587

30 September 2019

exact match

0 references

cites work

The first clinical use of depot buserelin for advanced prostatic carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2513141

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

An implant of a gonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3-5 months.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2513141

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2513141

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF00689587

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2513141%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 September 2019

0 references

1 reference